Impact of LS Mutation on Pharmacokinetics of Preventive HIV Broadly Neutralizing Monoclonal Antibodies: A Cross-Protocol Analysis of 16 Clinical Trials in People without HIV.

Mayer BT, Zhang L, deCamp AC, Yu C, Sato A, Angier H, Seaton KE, Yates N, Ledgerwood JE, Mayer K, Caskey M, Nussenzweig M, Stephenson K, Julg B, Barouch DH, Sobieszczyk ME, Edupuganti S, Kelley CF, McElrath MJ, Gelderblom HC, Pensiero M, McDermott A, Gama L, Koup RA, Gilbert PB, Cohen MS, Corey L, Hyrien O, Tomaras GD, Huang Y

Open source

DOI
10.3390/pharmaceutics16050594
Published
2024 Apr 27
Container
Pharmaceutics
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/pharmaceutics16050594,
  title = {Impact of LS Mutation on Pharmacokinetics of Preventive HIV Broadly Neutralizing Monoclonal Antibodies: A Cross-Protocol Analysis of 16 Clinical Trials in People without HIV.},
  author = {Mayer BT and Zhang L and deCamp AC and Yu C and Sato A and Angier H and Seaton KE and Yates N and Ledgerwood JE and Mayer K and Caskey M and Nussenzweig M and Stephenson K and Julg B and Barouch DH and Sobieszczyk ME and Edupuganti S and Kelley CF and McElrath MJ and Gelderblom HC and Pensiero M and McDermott A and Gama L and Koup RA and Gilbert PB and Cohen MS and Corey L and Hyrien O and Tomaras GD and Huang Y},
  year = {2024},
  journal = {Pharmaceutics},
  doi = {10.3390/pharmaceutics16050594},
  url = {https://doi.org/10.3390/pharmaceutics16050594}
}

RIS

TY  - JOUR
TI  - Impact of LS Mutation on Pharmacokinetics of Preventive HIV Broadly Neutralizing Monoclonal Antibodies: A Cross-Protocol Analysis of 16 Clinical Trials in People without HIV.
AU  - Mayer BT
AU  - Zhang L
AU  - deCamp AC
AU  - Yu C
AU  - Sato A
AU  - Angier H
AU  - Seaton KE
AU  - Yates N
AU  - Ledgerwood JE
AU  - Mayer K
AU  - Caskey M
AU  - Nussenzweig M
AU  - Stephenson K
AU  - Julg B
AU  - Barouch DH
AU  - Sobieszczyk ME
AU  - Edupuganti S
AU  - Kelley CF
AU  - McElrath MJ
AU  - Gelderblom HC
AU  - Pensiero M
AU  - McDermott A
AU  - Gama L
AU  - Koup RA
AU  - Gilbert PB
AU  - Cohen MS
AU  - Corey L
AU  - Hyrien O
AU  - Tomaras GD
AU  - Huang Y
PY  - 2024
JO  - Pharmaceutics
DO  - 10.3390/pharmaceutics16050594
UR  - https://doi.org/10.3390/pharmaceutics16050594
ER  - 

APA

BT, M., L, Z., AC, D., C, Y., A, S., H, A., KE, S., N, Y., JE, L., K, M., M, C., M, N., K, S., B, J., DH, B., ME, S., S, E., CF, K., MJ, M., HC, G., M, P., A, M., L, G., RA, K., PB, G., MS, C., L, C., O, H., GD, T., & Y, H. (2024). Impact of LS Mutation on Pharmacokinetics of Preventive HIV Broadly Neutralizing Monoclonal Antibodies: A Cross-Protocol Analysis of 16 Clinical Trials in People without HIV.. Pharmaceutics. https://doi.org/10.3390/pharmaceutics16050594

Source records